Journal
CLINICAL BIOCHEMISTRY
Volume 47, Issue 13-14, Pages 1227-1230Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.clinbiochem.2014.04.007
Keywords
Bone-specific alkaline phosphatase; Analytical variation; Standardization; Dialysis patients
Categories
Ask authors/readers for more resources
Background: Bone-specific alkaline phosphatase (BAP) is now recommended to assess bone turnover in hemodialysis (HD) patients. However, little is known about potential variability between methods available to measure BAP. Methods: We measured BAP in 76 HD patients with six different assays (Beckman-Coulter Ostase IRMA, Beckman-Coulter Ostase Access, IDS iSYS Ostase, IDS Ostase enzyme immunoassay, DiaSorin Liaison Ostase and Quidel MicroVue BAP). Results: We observed a high correlation between all the assays ranging from 0.9948 (IDS iSYS vs. IDS EIA) to 0.9215 (DiaSorin Liaison vs. Quidel MicroVue). However, using the regression equations, the equivalent concentration of a Beckman-Coulter Access value of 10 g/L can range from 7.7 to 14.4 mu g/L and of 20 mu g/L can range from 16.9 to 27.9 mu g/L with other assays. According to Beckman-Coulter Access, 13%, 50% and 37% of the patients presented BAP values <= 10, between 10 and >= 20 and = 20 mu g/L, respectively. Discrepancies are observed when other assays are used (concordance from 10 to 100%). Conclusions: Analytical problems leading to inter-method variation should be overcome to improve the usefulness of this marker in clinical practice. According to correlation results, recalibration of BAP assays is necessary but should not be a major issue. (C) 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available